Beta | Std.Err of beta | P-level | Adj R2 value | |
---|---|---|---|---|
Δ BMD L2 to L4, 0 to 24 months All patients | ||||
CRP 12 months | -0.25 | 0.09 | 0.006 | 14 to 16% |
P1NP 12 months | -0.26 | 0.10 | 0.009 | 14 to 16% |
Glucocorticoid-treatment (1 = yes, 2 = no) | 0.21 | 0.10 | 0.036 | 14 to 16% |
IGFSD, baseline | 0.17 | 0.09 | 0.059 | 14 to 16% |
Δ BMD L2 to L4, 0 to 24 months P-group | ||||
Gender (1 = woman, 2 = man) | 0.31 | 0.13 | 0.022 | 23 to 27% |
1CTP, 12 months | -0.25 | 0.12 | 0.045 | 23 to 27% |
IGFSD, baseline | 0.43 | 0.12 | 0.001 | 23 to 27% |
Δ BMD L2 to L4, 0 to 24 months NoP-group | ||||
P1NP, 12 months | -0.37 | 0.11 | 0.001 | 22 to 23% |
Gender (1 = woman, 2 = man) | -0.29 | 0.11 | 0.010 | 22 to 23% |
Δ BMD femoral neck, 0 to 24 months All patients | ||||
BMI | 0.31 | 0.08 | <0.001 | 23% |
CRP, 12 months | -0.20 | 0.08 | 0.017 | 23% |
1CTP, 12 months | -0.26 | 0.09 | 0.006 | 23% |
Δ BMD femoral neck, 0 to 24 months P-group | ||||
BMI | 0.37 | 0.14 | 0.010 | 17 to 20% |
1CTP, 12 months | -0.33 | 0.12 | 0.012 | 17 to 20% |
Δ BMD femoral neck, 0 to 24 months NoP-group | ||||
CRP, 12 months | -0.27 | 0.11 | 0.022 | 20 to 23% |
BMI | 0.35 | 0.11 | 0.003 | 20 to 23% |
1CTP, 12 months | -0.26 | 0.13 | 0.050 | 20 to 23% |